Osimertinib Resistance: Cellular Mechanisms in Adenocarcinoma Study
Here’s a breakdown of the details provided in the text:
Research Paper Details:
* Title: Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification
* Authors: Rebecca M. Starble et al.
* Journal: Nature Structural & Molecular Biology
* Year: 2025
* DOI: 10.1038/s41594-025-01685-4
* Link: https://dx.doi.org/10.1038/s41594-025-01685-4
Source of Information:
* Provided by: Yale School of Medicine
* yale School of Medicine website: https://medicine.yale.edu/
News Article Details (for citation):
* Title: Study sheds light on cellular resistance too osimertinib in adenocarcinoma
* Date Published: November 19,2025
* Date Retrieved: November 19,2025 (This is the date the information was accessed/used)
In essence,this text is a snippet from a news article reporting on a research paper published in Nature Structural & Molecular biology about cancer drug resistance.